Back to Trades
Total Value
$90.7K
Filing Date
Apr 16, 2026
1 transactions
Trade Summary
On Apr 15, 2026, Wainman Paul R, Director, reported $90.7K of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $7.60. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- IMMUCELL CORP /DE/
- Ticker Symbol
- ICCC
- CIK
- 0000811641
Insider Information
- Name
- Wainman Paul R
- Role
- Director
- Location
- PORTLAND, ME
Filing Details
- Filing Date
- Apr 16, 2026
- Transaction Date
- Apr 15, 2026
- Accession Number
- 0001437749-26-012551
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 15, 2026 | ICCC derivative | 11,933 | $7.60 | Grant/Award | $90.7K |
Want live alerts when Wainman Paul R trades again?
Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029.